EP 4081191 A1 20221102 - ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS
Title (en)
ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS
Title (de)
ENTZÜNDUNGSHEMMENDE DENDRIMERFORMULIERUNG ZUR BEHANDLUNG VON PSORIASIS
Title (fr)
FORMULATION D'UN DENDRIMÈRE ANTI-INFLAMMATOIRE POUR LE TRAITEMENT DE PSORIASIS
Publication
Application
Priority
- FR 1915517 A 20191223
- FR 2020052608 W 20201222
Abstract (en)
[origin: CA3165406A1] The present invention relates to sugar-derived catanionic surfactant vesicles comprising anti-inflammatory dendrimers and to their use as a medicament, more particularly in the treatment of psoriasis.
IPC 8 full level
A61K 9/127 (2006.01); A61K 31/675 (2006.01); A61K 31/80 (2006.01); A61K 47/30 (2006.01); A61P 17/06 (2006.01)
CPC (source: EP IL US)
A61K 9/127 (2013.01 - EP IL); A61K 9/1277 (2013.01 - EP IL); A61K 31/66 (2013.01 - US); A61K 31/675 (2013.01 - EP IL); A61K 31/80 (2013.01 - EP IL US); A61K 47/30 (2013.01 - EP IL US); A61P 17/06 (2017.12 - EP IL US)
Citation (search report)
See references of WO 2021130453A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
FR 3104946 A1 20210625; FR 3104946 B1 20220812; AU 2020412366 A1 20220714; CA 3165406 A1 20210701; EP 4081191 A1 20221102; IL 294186 A 20220801; US 2023085651 A1 20230323; WO 2021130453 A1 20210701
DOCDB simple family (application)
FR 1915517 A 20191223; AU 2020412366 A 20201222; CA 3165406 A 20201222; EP 20851221 A 20201222; FR 2020052608 W 20201222; IL 29418622 A 20220621; US 202017787787 A 20201222